Related references
Note: Only part of the references are listed.Targeting the mTOR kinase domain: the second generation of mTOR inhibitors
Yan-Jie Zhang et al.
DRUG DISCOVERY TODAY (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E
Andrew C. Hsieh et al.
CANCER CELL (2010)
4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
Qing-Bai She et al.
CANCER CELL (2010)
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
Christine M. Chresta et al.
CANCER RESEARCH (2010)
Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy
Stephen L. Abrams et al.
CELL CYCLE (2010)
Reduced mortality and moderate alcohol consumption The phospholipase D-mTOR connection
David A. Foster
CELL CYCLE (2010)
Increasing healthy lifespan by suppressing aging in our lifetime Preliminary proposal
Mikhail V. Blagosklonny
CELL CYCLE (2010)
Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition
Calvin K. Yip et al.
MOLECULAR CELL (2010)
Critical roles for mTORC2-and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells
Nathalie Carayol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs
Ryan J. O. Dowling et al.
SCIENCE (2010)
Validation of anti-aging drugs by treating age-related diseases
Mikhail V. Blagosklonny
AGING-US (2009)
p53-Dependent Translational Control of Senescence and Transformation via 4E-BPs
Emmanuel Petroulakis et al.
CANCER CELL (2009)
Overcoming resistance to tyrosine kinase inhibitors Lessons learned from cancer cells treated with EGFR antagonists
Brent N. Rexer et al.
CELL CYCLE (2009)
Targeting mTOR with rapamycin One dose does not fit all
David A. Foster et al.
CELL CYCLE (2009)
Not all substrates are treated equally Implications for mTOR, rapamycin-resistance and cancer therapy
Andrew Y. Choo et al.
CELL CYCLE (2009)
Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma
Kathryn E. O'Reilly et al.
CLINICAL CANCER RESEARCH (2009)
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
Carson C. Thoreen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Regulation of mTORC1 and mTORC2 Complex Assembly by Phosphatidic Acid: Competition with Rapamycin
Alfredo Toschi et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Enhancing mammalian target of rapamycin (mTOR)-targeted cancer therapy by preventing mTOR/raptor inhibition-initiated, mTOR/rictor-independent Akt activation
Xuerong Wang et al.
CANCER RESEARCH (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumors
Antonio Jimeno et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: A phase I tumor pharmacodynamic study in patients with advanced solid tumors
Josep Tabernero et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
Andrew Y. Choo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-Deficient glioblastoma
Tim F. Cloughesy et al.
PLOS MEDICINE (2008)
Defective TGF-β signaling sensitizes human cancer cells to rapamycin
N. Gadir et al.
ONCOGENE (2008)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition
SY Sun et al.
CANCER RESEARCH (2005)
Regulation of cap-dependent translation by eIF4E inhibitory proteins
JD Richter et al.
NATURE (2005)
Alternative phospholipase D/mTOR survival signal in human breast cancer cells
YH Chen et al.
ONCOGENE (2005)
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
HG Wendel et al.
NATURE (2004)
Efficient synthesis and photodynamic activity of porphyrin-saccharide conjugates: Targeting and incapacitating cancer cells
X Chen et al.
BIOCHEMISTRY (2004)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
Therapeutic potential of target of rapamycin inhibitors
JB Easton et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2004)
Effect of rapamycin alone and in combination with antiangiogenesis therapy in an orthotopic model of human pancreatic cancer
S Stephan et al.
CLINICAL CANCER RESEARCH (2004)
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
D Ruggero et al.
NATURE MEDICINE (2004)
Phospholipase D confers rapamycin resistance in human breast cancer cells
YH Chen et al.
ONCOGENE (2003)
MTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
DH Kim et al.
CELL (2002)
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
MS Neshat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice
K Podsypanina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Regulation of translation initiation by FRAP/mTOR
AC Gingras et al.
GENES & DEVELOPMENT (2001)
Share Paper
